Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/06/2003WO2003091280A1 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same
11/06/2003WO2003091273A2 Protein interaction system for multisubunit complexes
11/06/2003WO2003091271A1 Alternatively spliced nucleic acid molecules
11/06/2003WO2003091267A1 Process for preparing oligonucleotides
11/06/2003WO2003091266A2 Protein stabilisation using chaperone proteins
11/06/2003WO2003091231A1 Pna monomer and precursor
11/06/2003WO2003090897A1 Structure and method for handling magnetic particles in biological assays
11/06/2003WO2003090788A1 DECOY FOR TREATING AND/OR PREVENTING Th2 CYTOKINE-ASSOCIATED ALLERGIC DISEASE, GATA3 MUTANT PROTEIN AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
11/06/2003WO2003090778A2 Dna vaccine combined with an inducer of tumor cell apoptosis
11/06/2003WO2003090719A1 Histidine copolymer and methods for using same
11/06/2003WO2003090695A2 TREATMENT OF α-GALACTOSIDASE A DEFICIENCY
11/06/2003WO2003090694A2 Methods and compositions for diagnosing and monitoring auto immune and chronic inflammatory diseases
11/06/2003WO2003090689A2 Neurodegenerative disorder treatment using gdnf secreting neural cells
11/06/2003WO2003090667A2 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus
11/06/2003WO2003090664A2 Mutated hpv-16 e7 polypeptide, pharmaceutical composition comprising it and its preparation process
11/06/2003WO2003090526A1 Production of cloned offspring from cooled carcasses
11/06/2003WO2003090521A2 Tomato plants that exhibit resistance to botrytis cinerea
11/06/2003WO2003090515A2 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation
11/06/2003WO2003090514A2 Adipocyte complement related protein zacrp14
11/06/2003WO2003090512A2 Regeneration of endogenous myocardial tissue by induction of neovascularization
11/06/2003WO2003080112A3 Imidazoquinolineamines as adjuvants in hiv dna vaccination
11/06/2003WO2003074700A3 Transposon
11/06/2003WO2003072822A9 Mononucleotide repeats microsatellite markers for detecting microsatellite instability.
11/06/2003WO2003072711A3 Method of using modified oligonucleotides for hepatic delivery
11/06/2003WO2003072705A3 Rna interference mediated inhibition of cyclin d1 gene expression using short interfering nucleic acid (sina)
11/06/2003WO2003070898A3 Selective extraction of dna from groups of cells
11/06/2003WO2003070171A3 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
11/06/2003WO2003068153A3 CARDIAC-SPECIFIC 11β HYDROXYSTEROID DEHYDROGENASE TYPE 2 TRANSGENIC MICE
11/06/2003WO2003062269A3 Corticotropin releasing factor receptor 2 agonists
11/06/2003WO2003059945A3 Soluble recombinant protein production
11/06/2003WO2003055983A3 Targeted retrograde gene delivery to motor neurons
11/06/2003WO2003054541A3 Inhibition of tristetraproline for protection of the heart from cardiac injuries
11/06/2003WO2003054139A3 Compositions and methods utilizing dna polymerases
11/06/2003WO2003052124A3 Screening method for agents useful in treating diabetes
11/06/2003WO2003049766A3 Method of purifying hepatitis a virus particles and vaccine preparation
11/06/2003WO2003048327A3 Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection
11/06/2003WO2003040395A3 Universal nucleotides for nucleic acid analysis
11/06/2003WO2003040328A3 Antisense modulation of thyroid hormone receptor interactor 6 expression
11/06/2003WO2003040318A3 Method and system for inducible recombinational cloning in bacterial cells
11/06/2003WO2003031939A3 Protein modification and maintenance molecules
11/06/2003WO2003027638A3 Methods for detecting genetic mosaicisms using arrays
11/06/2003WO2003027321A3 Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin
11/06/2003WO2003027307A3 Nucleic acid sequencing by raman monitoring of uptake of precursors during molecular replication
11/06/2003WO2003027263A3 Proteins associated with cell growth, differentiation, and death
11/06/2003WO2003027237A3 Method of modulating or examining ku70 levels in cells
11/06/2003WO2003023021A3 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture
11/06/2003WO2003020885B1 Identification of sortase gene
11/06/2003WO2003018745A3 Method of screening for drug hypersensitivity reaction
11/06/2003WO2003016568A3 Yeast arrays, methods of making such arrays, and methods of analyzing such arrays
11/06/2003WO2003016354A3 Recombinant anti-plasmodium falciparum antibodies
11/06/2003WO2003015714A3 Compositions and therapeutic methods for viral infection
11/06/2003WO2003014388A3 Method and nucleic acids for the analysis of colon cancer
11/06/2003WO2003012124A3 Methods for immobilizing molecules to a solid phase and uses thereof
11/06/2003WO2003012106A3 Regulating nucleic acid for expressing a polynucleotide of interest specifically in the endothelium of a plant seed and uses thereof
11/06/2003WO2003012071A3 Nucleic acids of aspergillus fumigatus encoding industrial enzymes and methods of use
11/06/2003WO2003012069A3 Compositions and methods for generating chimeric heteromultimers
11/06/2003WO2003012031A3 Antisense modulation of stearoyl-coa desaturase expression
11/06/2003WO2003011878A3 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
11/06/2003WO2003008588A3 Method for producing 2-keto-l-gulonic acid and vitamin c while using l-sorbose dehydrogenase and l-sorbosone dehydrogenase
11/06/2003WO2003008555A3 Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier
11/06/2003WO2003006602A3 Subtilase variants
11/06/2003WO2003006496A3 Protein variants of neocarzinostatine and its homologues and their use
11/06/2003WO2003005880A3 Replikin peptides and uses thereof
11/06/2003WO2003004690A3 Method for isolation of independent, parallel chemical micro-reactions using a porous filter
11/06/2003WO2003003906A3 Diagnostic and screening methods for bladder cancer
11/06/2003WO2003002604A3 G protein coupled receptors and dna sequences thereof
11/06/2003WO2002102318A3 Eglin c based drugs for treatment of disease
11/06/2003WO2002099034A3 Sequences for detection and identification of methicillin-resistant staphyloccocus aureus
11/06/2003WO2002098916A3 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
11/06/2003WO2002096939A3 Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization
11/06/2003WO2002095008A3 Methods of modulating surfactant phospholipid production
11/06/2003WO2002094845A3 Method for stabilising of nucleic acids
11/06/2003WO2002094313A3 Vaccine composition
11/06/2003WO2002092773A3 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/06/2003WO2002090523A3 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamic acid
11/06/2003WO2002086126A3 Enzymatic method for the enantioselective reduction of keto compounds
11/06/2003WO2002083903A3 West nile virus epitopes and uses thereof
11/06/2003WO2002083854A9 Antibodies to vla-1
11/06/2003WO2002083711A3 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
11/06/2003WO2002082043A3 Transgenic zebrafish models for neurodegenerative diseases
11/06/2003WO2002081741A3 Use of products of genes of the 2'-5' oligoadenylate synthetase family (oas) for screening antiviral agents and for detecting responsiveness to flaviviridae infection
11/06/2003WO2002081714A3 Overexpression of phosphoenolpyruvate carboxylase
11/06/2003WO2002079507A3 Method for specifically detecting, isolating and characterizing cells from body samples by transfecting nucleic acid constructs
11/06/2003WO2002079258A3 Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations
11/06/2003WO2002079242A3 Adp-ribosylating bacterial toxins
11/06/2003WO2002075317A3 Screening for drugs against disorders associated with schizophrenia
11/06/2003WO2002074078B1 Method for embryo after impregnation of the recipient female
11/06/2003WO2002073207A3 Isolated ductal fluid sample
11/06/2003WO2002072600A3 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections
11/06/2003WO2002070667A3 High level insect expression of rage proteins
11/06/2003WO2002070657A8 93870, a human g-protein coupled receptor and uses therefor
11/06/2003WO2002068666A8 Manipulation of the phenolic acid content and digestibility of plant cell walls by targeted expression of genes encoding cell wall degrading enzymes
11/06/2003WO2002068648A3 Isolated human ras-like proteins, nucleic acid molecules encoding these humans ras-like proteins, and uses thereof
11/06/2003WO2002068646A3 Mammalian cytokines; receptors; related reagents and methods
11/06/2003WO2002066649A8 ANTI-INTERFERON-α ANTIBODIES
11/06/2003WO2002063025A3 Muscle-directed gene therapy with aav-1 and aav-6 vectors
11/06/2003WO2002063023A3 Sustained totipotent regenerable tissue culture of arundo donax (giant reed) and totipotent tissue and plants produced therefrom
11/06/2003WO2002062945A3 Compositions and methods relating to lung specific genes and proteins
11/06/2003WO2002061142A3 Methods for homology-driven reassembly of nucleic acid sequences
11/06/2003WO2002061115A3 Method for the evolutionary design of biochemical reaction networks
1 ... 2380 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 ... 4023